This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
How can we reduce the burden of cancer?
Implementing the research agenda of the National Cancer Institute’s Cancer Epidemiology and Genetics Program
Challenge
Scientists at the National Cancer Institute’s (NCI’s) Division of Cancer Epidemiology and Genetics (DCEG) work to understand genetic and environmental determinants of cancer. They study many different types of cancer, employ a wide range of study designs, include diverse populations, and collect a broad array of epidemiologic and clinical data, as well as biological and environmental samples.
These complex, multidisciplinary studies need considerable infrastructure and resources for successful conduct, such as clinical staff and experts in the collection and handling of biological and environmental samples. For many of DCEG’s longitudinal cohort studies, expertise is needed in long-term followup methods and linking cohorts to disease and death registries. Most studies require acquiring, editing, merging, and harmonizing data from multiple sources sometimes collected over the course of many years; maintaining the data in secure databases; and preparing analytic datasets.
Solution
For more than 40 years, Westat has provided research support services to DCEG investigators. We currently hold 4 task order contracts supporting 5 branches within the Division.
Our large and highly skilled workforce has advanced, specialized capabilities in
- Multimode data collection from individuals and healthcare delivery sources
- Clinical data collection
- Biological and environmental sample collection and management
- Exposure assessment
- Geospatial analysis
- Data linkages
- Management of complex biomedical data from multiple sources
We successfully manage multiple studies conducted concurrently and respond quickly to address newly emerging scientific questions. Many of the studies we support are international, and we have effectively negotiated subcontracts and monitored research activities on every continent, including in low- and middle-income countries.
Results
Westat is proud to support research that has made major contributions to our understanding of the causes, progression, prevention, and detection of cancer. Examples include studies that have identified genetic mutations associated with cancer in high-risk individuals, studies to understand the associations of infections with cancer and progression from precancerous lesions, and studies to understand the interrelationships between environmental and genetic factors in cancer.
-
Perspective
Public Health in Action: Westat APHA 2024 HighlightsNovember 2024
Westat staff made their mark at the 2024 American Public Health Association (APHA) Annual Meeting and Expo, which was held in Minneapolis, Minnesota, October 27-30.…
-
Expert Interview
Timely Data-Driven Solutions for Nursing HomesNovember 2024
The COVID-19 pandemic has had a devastating impact on the nursing home sector, resulting in hundreds of thousands of deaths of residents and staff and…
-
Perspective
Westat Work Shines at 2024 APHSA EMWB ConferenceSeptember 2024
Westat human services experts recently presented at the American Public Human Services Association (APHSA)’s Economic Mobility and Well-Being (EMWB) Conference in Portland, Oregon. At the…